US Stock MarketDetailed Quotes

ICCM Icecure Medical

Watchlist
  • 0.658
  • -0.005-0.77%
Close Aug 2 16:00 ET
  • 0.660
  • +0.002+0.30%
Post 20:01 ET
31.54MMarket Cap-2055P/E (TTM)

Icecure Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
4.65%743K
4.67%3.23M
33.65%1.26M
-48.42%327K
22.48%937K
-4.95%710K
-25.45%3.09M
-32.15%939K
-6.90%634K
20.09%765K
Operating revenue
4.65%743K
4.67%3.23M
33.65%1.26M
-48.42%327K
22.48%937K
-4.95%710K
-25.45%3.09M
-32.15%939K
-6.90%634K
20.09%765K
Cost of revenue
21.54%474K
17.62%1.93M
43.51%686K
-25.21%350K
32.02%503K
24.60%390K
-15.59%1.64M
-35.49%478K
45.34%468K
-0.52%381K
Gross profit
-15.94%269K
-10.03%1.3M
23.43%569K
-113.86%-23K
13.02%434K
-26.27%320K
-34.17%1.45M
-28.30%461K
-53.76%166K
51.18%384K
Operating expense
-8.37%3.92M
-7.19%16.88M
-9.31%3.98M
-3.91%4.1M
-3.22%4.52M
-11.98%4.28M
52.56%18.18M
16.49%4.39M
32.97%4.27M
66.19%4.67M
Selling and administrative expenses
-9.14%1.97M
-5.05%8.6M
-2.55%2.1M
-6.40%1.9M
1.08%2.44M
-12.13%2.17M
49.97%9.06M
-0.65%2.16M
22.07%2.03M
97.38%2.41M
-Selling and marketing expense
-3.44%1.04M
16.55%1.21M
-68.72%-2.02M
39.15%981K
49.87%1.18M
43.91%1.08M
56.01%1.04M
-117.60%-1.2M
19.09%705K
140.37%786K
-General and administrative expense
-14.76%930K
-7.85%7.39M
22.92%4.12M
-30.64%919K
-22.54%1.26M
-36.50%1.09M
49.22%8.02M
23.30%3.36M
23.72%1.33M
81.66%1.62M
Research and development costs
-7.58%1.95M
-9.32%8.27M
-15.82%1.88M
-1.65%2.2M
-7.80%2.08M
-11.82%2.11M
55.23%9.12M
39.73%2.24M
44.70%2.24M
42.18%2.26M
Operating profit
7.76%-3.65M
6.95%-15.58M
13.15%-3.42M
-0.54%-4.12M
4.67%-4.08M
10.58%-3.96M
-72.14%-16.74M
-25.70%-3.93M
-43.89%-4.1M
-67.69%-4.28M
Net non-operating interest income expense
-78.31%41K
486.61%924K
2,200.00%420K
186.05%123K
180.00%192K
959.09%189K
-39.77%-239K
37.50%-20K
213.16%43K
-411.69%-240K
Total other finance cost
78.31%-41K
-486.61%-924K
-2,200.00%-420K
-186.05%-123K
-180.00%-192K
-959.09%-189K
39.77%239K
--20K
---43K
--240K
Other net income (expense)
Income before tax
4.22%-3.61M
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
-40.51%-4.06M
-82.59%-4.52M
Income tax
Net income
4.22%-3.61M
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
-40.51%-4.06M
-82.59%-4.52M
Net income continuous Operations
4.22%-3.61M
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
-40.51%-4.06M
-82.59%-4.52M
Minority interest income
Net income attributable to the parent company
4.22%-3.61M
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
-40.51%-4.06M
-82.59%-4.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4.22%-3.61M
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
-40.51%-4.06M
-82.59%-4.52M
Basic earnings per share
0.00%-0.08
30.43%-0.32
38.68%-0.065
20.91%-0.087
29.03%-0.088
33.33%-0.08
-31.43%-0.46
-4.95%-0.106
-18.28%-0.11
-44.19%-0.124
Diluted earnings per share
0.00%-0.08
30.43%-0.32
38.68%-0.065
20.91%-0.087
29.03%-0.088
33.33%-0.08
-31.43%-0.46
-4.95%-0.106
-18.28%-0.11
-44.19%-0.124
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 4.65%743K4.67%3.23M33.65%1.26M-48.42%327K22.48%937K-4.95%710K-25.45%3.09M-32.15%939K-6.90%634K20.09%765K
Operating revenue 4.65%743K4.67%3.23M33.65%1.26M-48.42%327K22.48%937K-4.95%710K-25.45%3.09M-32.15%939K-6.90%634K20.09%765K
Cost of revenue 21.54%474K17.62%1.93M43.51%686K-25.21%350K32.02%503K24.60%390K-15.59%1.64M-35.49%478K45.34%468K-0.52%381K
Gross profit -15.94%269K-10.03%1.3M23.43%569K-113.86%-23K13.02%434K-26.27%320K-34.17%1.45M-28.30%461K-53.76%166K51.18%384K
Operating expense -8.37%3.92M-7.19%16.88M-9.31%3.98M-3.91%4.1M-3.22%4.52M-11.98%4.28M52.56%18.18M16.49%4.39M32.97%4.27M66.19%4.67M
Selling and administrative expenses -9.14%1.97M-5.05%8.6M-2.55%2.1M-6.40%1.9M1.08%2.44M-12.13%2.17M49.97%9.06M-0.65%2.16M22.07%2.03M97.38%2.41M
-Selling and marketing expense -3.44%1.04M16.55%1.21M-68.72%-2.02M39.15%981K49.87%1.18M43.91%1.08M56.01%1.04M-117.60%-1.2M19.09%705K140.37%786K
-General and administrative expense -14.76%930K-7.85%7.39M22.92%4.12M-30.64%919K-22.54%1.26M-36.50%1.09M49.22%8.02M23.30%3.36M23.72%1.33M81.66%1.62M
Research and development costs -7.58%1.95M-9.32%8.27M-15.82%1.88M-1.65%2.2M-7.80%2.08M-11.82%2.11M55.23%9.12M39.73%2.24M44.70%2.24M42.18%2.26M
Operating profit 7.76%-3.65M6.95%-15.58M13.15%-3.42M-0.54%-4.12M4.67%-4.08M10.58%-3.96M-72.14%-16.74M-25.70%-3.93M-43.89%-4.1M-67.69%-4.28M
Net non-operating interest income expense -78.31%41K486.61%924K2,200.00%420K186.05%123K180.00%192K959.09%189K-39.77%-239K37.50%-20K213.16%43K-411.69%-240K
Total other finance cost 78.31%-41K-486.61%-924K-2,200.00%-420K-186.05%-123K-180.00%-192K-959.09%-189K39.77%239K--20K---43K--240K
Other net income (expense)
Income before tax 4.22%-3.61M13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M-40.51%-4.06M-82.59%-4.52M
Income tax
Net income 4.22%-3.61M13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M-40.51%-4.06M-82.59%-4.52M
Net income continuous Operations 4.22%-3.61M13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M-40.51%-4.06M-82.59%-4.52M
Minority interest income
Net income attributable to the parent company 4.22%-3.61M13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M-40.51%-4.06M-82.59%-4.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4.22%-3.61M13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M-40.51%-4.06M-82.59%-4.52M
Basic earnings per share 0.00%-0.0830.43%-0.3238.68%-0.06520.91%-0.08729.03%-0.08833.33%-0.08-31.43%-0.46-4.95%-0.106-18.28%-0.11-44.19%-0.124
Diluted earnings per share 0.00%-0.0830.43%-0.3238.68%-0.06520.91%-0.08729.03%-0.08833.33%-0.08-31.43%-0.46-4.95%-0.106-18.28%-0.11-44.19%-0.124
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg